Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine. - Wikidata - awgldk - TriplyDB

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

http://www.wikidata.org/entity/Q46375786

about

CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes.Protective Effect of Boiled and Freeze-dried Mature Silkworm Larval Powder Against Diethylnitrosamine-induced Hepatotoxicity in Mice.Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects Different physiology of interferon-α/-γ in models of liver regeneration in the rat.The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine.Therapeutic role of a synthesized calcium phosphate nanocomposite material on hepatocarcinogenesis in rats.Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

P2860

Q35067403-082FE3D7-DA6F-408F-992D-E5216C343795 Q35312100-B03D1185-5061-49DB-9330-E19AC7BECEC4 Q36335764-230FBCCC-C4B8-4C52-AAFB-BA08C86D61A0 Q37131434-E7CDE391-BE6E-4A89-B821-1DF3C73DA795 Q37312925-59710293-F752-4727-884D-2F8D45A9D268 Q38806938-BF61E93A-0A7F-4399-B211-AEC949F4408F Q39829446-C4919AC4-9A84-4FB4-A345-9DCFB80581F1 Q42397962-37087CEB-11AE-4157-87C9-C841D770C194 Q42857638-5DF561C6-E464-44E1-A8E9-F368D070080D Q46409639-C9492512-BA47-4804-81AC-38D4EB38C3BC Q46581151-22854E08-BA24-48D2-ADFC-A25BFB468500 Q48799977-CCDB379B-930D-4B3C-BCCF-D05CA715CBF9

P2860

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

http://www.wikidata.org/entity/Q46375786

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@en

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@nl

type

label

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@en

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@nl

prefLabel

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@en

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@nl

P1433

Q46375786-DA851D3A-5793-4A8A-97E4-0B2A8A85E655

P1476

Q46375786-159D5FAD-CA27-48DF-AB05-8263524D8569

P2093

Q46375786-0A7840AF-EDF4-4AF6-AD7A-2277B83722F5

Q46375786-13521DE0-E9DA-447D-AB36-B7AEA5B4210F

Q46375786-3FCCE94B-E3BC-40A3-B231-3BC0B369BAAC

Q46375786-615A1F2A-006F-47C5-AFBF-CFBA00C772FF

Q46375786-A7DCFD4E-BA7A-42E7-AC64-1E3450A8094A

P2860

Q46375786-204A1410-154A-4AE4-92AC-6D77C342AC02

Q46375786-5726C0C5-1955-49EC-9C2B-43EA9B44BFE8

Q46375786-585086C8-57F4-4F5C-AF90-EBC71F3FA1EE

Q46375786-65823638-3C23-4746-ADB1-AB01CD9D5230

Q46375786-81EF2C83-89B5-453E-B4AA-756865EA0185

Q46375786-962A3294-C96B-4DFB-8082-CA22015DB5E8

Q46375786-AA822A22-C9B2-4BCB-81E4-628CBEC6C57E

Q46375786-ACC9FEB6-3C90-4109-B9D7-3448ECB45375

Q46375786-B4EB1F8A-FD04-4E8D-AB89-97E118E35EDD

Q46375786-D6195895-A5A0-4225-876B-583C309C9DAD

P2888

Q46375786-CE485C73-4922-4FB8-BA85-D6C298EE20DC

P304

Q46375786-94FF9DD1-4EF9-4C5A-9C6D-84D008DB64B5

P31

Q46375786-EF812672-8C5E-443F-BE4D-B4A8919468ED

P356

Q46375786-17965F55-D451-4A1B-AF7C-1277D19B1BC1

P433

Q46375786-BB998EB6-4537-4ABD-82B2-B80D96081D4E

P478

Q46375786-4A3C3A35-E0BD-4A60-A1AB-075285E815AD

P577

Q46375786-14A18985-3BE9-4FD4-A14D-0BC84D13AA41

P5875

Q46375786-89D39A92-BB4F-4D89-9217-6111FF04B899

P698

Q46375786-FEF8AC6E-4962-4AE6-8FC7-50DB883FCA47

P356

LABINVEST.3700257

P1433

Laboratory Investigation

P1476

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

@en

P2093

Mitsuru Matsuda

http://www.w3.org/2001/XMLSchema#string

Satoshi Suzuki

http://www.w3.org/2001/XMLSchema#string

Shuichi Kaneko

http://www.w3.org/2001/XMLSchema#string

Tomomitsu Kurata

http://www.w3.org/2001/XMLSchema#string

Yasunari Nakamoto

http://www.w3.org/2001/XMLSchema#string

P2860

N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation

Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver

Hepatocellular carcinoma: recent progress.

Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines

Mutagenesis associated with nitric oxide production in macrophages

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy.

Immune pathogenesis of hepatocellular carcinoma.

Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment.

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.

Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine.

P2888

labinvest.3700257

P304

655-663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3700257

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7969691

http://www.w3.org/2001/XMLSchema#string

P698

15765122

http://www.w3.org/2001/XMLSchema#string